ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,655
Screening encounters
4,264
Diagnostic referrals
812
Outstanding pathways
293

Screening pathway

  1. Screening4,264Encounters
  2. Positive finding1,469Documented findings
  3. Referral812Diagnostic referrals
  4. Follow-up953Diagnostic visits
  5. Outcome519Resolved pathways

Stage totals use different units. Pending pathways: 293. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0189 · EXP-0189Synthetic · Site D

Full participant history through 2026-10-13, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · LSIL · Adequate
  3. · Diagnostic referral · EXP-0189-T-R
  4. · Contact attempt · Reached
  5. · Diagnostic booking · Initial booking
  6. · Barrier documented · Transport difficulty
  7. · Barrier documented · Contact difficulty
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-25
  13. · Follow-up disposition · Resolved · EXP-0189-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3655 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0529 · Expanded synthetic participant 0529Site C — Rural Outreach Programme
EXP-0531 · Expanded synthetic participant 0531Site D — Community Engagement Programme
EXP-0532 · Expanded synthetic participant 0532Site D — Community Engagement Programme
EXP-0533 · Expanded synthetic participant 0533Site C — Rural Outreach Programme
EXP-0534 · Expanded synthetic participant 0534Site B — Peri-Urban Access Programme
EXP-0536 · Expanded synthetic participant 0536Site D — Community Engagement Programme
EXP-0537 · Expanded synthetic participant 0537Site B — Peri-Urban Access Programme
EXP-0538 · Expanded synthetic participant 0538Site A — Urban Referral Hub
EXP-0539 · Expanded synthetic participant 0539Site B — Peri-Urban Access Programme
EXP-0540 · Expanded synthetic participant 0540Site E — Resource-Constrained Navigation Programme
EXP-0541 · Expanded synthetic participant 0541Site B — Peri-Urban Access Programme
EXP-0543 · Expanded synthetic participant 0543Site A — Urban Referral Hub
EXP-0545 · Expanded synthetic participant 0545Site E — Resource-Constrained Navigation Programme
EXP-0547 · Expanded synthetic participant 0547Site A — Urban Referral Hub
EXP-0548 · Expanded synthetic participant 0548Site A — Urban Referral Hub
EXP-0549 · Expanded synthetic participant 0549Site D — Community Engagement Programme
EXP-0550 · Expanded synthetic participant 0550Site E — Resource-Constrained Navigation Programme
EXP-0551 · Expanded synthetic participant 0551Site A — Urban Referral Hub
EXP-0552 · Expanded synthetic participant 0552Site D — Community Engagement Programme
EXP-0553 · Expanded synthetic participant 0553Site D — Community Engagement Programme
EXP-0554 · Expanded synthetic participant 0554Site D — Community Engagement Programme
EXP-0556 · Expanded synthetic participant 0556Site E — Resource-Constrained Navigation Programme
EXP-0557 · Expanded synthetic participant 0557Site A — Urban Referral Hub
EXP-0558 · Expanded synthetic participant 0558Site B — Peri-Urban Access Programme
EXP-0559 · Expanded synthetic participant 0559Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1659
HPV DNA
2006
Cytology
599

Navigation activity

Barrier documented
716
Contact attempt
1189
Navigation intervention
306
Diagnostic booking
1008
Diagnostic visit
953

Documented barriers

Contact difficulty
230
Transport difficulty
233
Appointment coordination
253

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.